Grantors & Exhibitors
We thank the following Grantors and Exhibitors for their support in helping to make this conference possible.
We are committed to helping our clients solve their most complex issues. Deloitte Risk and Financial Advisory professionals help our clients view change as opportunity for innovation and strategic movement. From threats that require immediate mitigation, to operational uncertainties, and everything in between, we focus on the full continuum and constantly innovate to see risk in its many dimensions. At Deloitte, we help our clients lead, navigate, and disrupt through complexities, to create a strategic advantage and accelerate performance. For more information, Click Here.
Fraud Investigation & Dispute Services, Life Sciences team
Industry insight and global experience: the intelligent connection
Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing.
Our professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. By making the intelligent connection between your business operations, markets and third-party relationships, we can help you get to the root cause of problems arising from impropriety. Our dedicated team includes CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.
For more information visit www.ey.com/fids or contact Ted Acosta, Principal, Fraud Investigation & Dispute Services +1 212 773 3022 (email@example.com), Mariusz Witalis, Partner, Fraud Investigation & Dispute Services +48 22 557 7950, (Mariusz.Witalis@pl.ey.com), or Rajiv Joshi, Partner, Fraud Investigation & Dispute Services +91 22 61921569 (firstname.lastname@example.org)
Our lawyers have acted as trusted advisers to the world’s largest healthcare companies for more than half a century. Among the first firms to provide comprehensive industry advice — covering biopharmaceuticals, medical devices, and healthcare services — we have broad experience and a sophisticated understanding of the global life sciences market that few can match. We help healthcare companies soundly navigate intensifying legal and commercial risks, realize opportunities for expansion and growth, and stay ahead of the innovation curve.
Our international network spans 47 countries, including the largest healthcare markets in the world. Many of our practices — including M&A, Tax, Compliance, Healthcare Regulatory, Employment, Intellectual Property, and Dispute Resolution — are ranked among the world’s leading. Our lawyers have developed a depth of knowledge in the industry in respect of various market players including manufacturers, distributors, research institutions, clinical trial bases and health and regulatory authorities. For more information www.BakerMcKenzie.com.
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.
G&M Health, LLC is a health and life-science service company offering compliance management services, computer validation, project management, audits & assessments, aggregate spend services, Corporate Integrity Agreement (CIA) management, training and regulatory support services. G&M was founded by recognized legal and regulatory compliance experts in the healthcare industry, who have worked with and/or advised over 100 pharmaceutical and biotech companies over the last 20 years. Our mission is to be the premier provider of innovative, quality, efficient and compliance-oriented solutions for the healthcare industry.
For more information, visit www.gmhllc.com/new/.
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 900 lawyers in 19 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, for uncompromising commitment to quality and for dedication to understanding the business and culture of its clients. King & Spalding was recently chosen by U.S. News & World Report and Best Lawyers as the “Law Firm of the Year” for FDA law and LMG Life Sciences selected the firm as one of the finalists for “Regulatory Firm of the Year.”
For more information about our FDA & Life Sciences practice, please contact Mark Brown at (202) 626-5443. www.kslaw.com
Paul Hastings provides innovative compliance and legal solutions to many of the world’s top pharmaceutical and life sciences companies, large and small, in markets across Asia, Europe, Latin America, and the United States. We offer a complete portfolio of services to support our clients’ complex, often mission-critical needs–from structuring transactions, to protecting critical intellectual property, to resolving complicated U.S. healthcare and global anti-corruption enforcement matters, to providing the savvy compliance and legal counsel that keeps business moving forward.
Paul Hastings has grown steadily and strategically along with our clients across global markets in the critical pharmaceutical and life sciences sector. We have a significant and strategic presence across Europe, and were one of the first U.S. law firms to establish a presence in Asia, where we continue to be a leader in the region, and have significantly expanded our support for clients in Brazil, out of our new São Paulo office, and other emerging markets of Latin America.
More information can be found at www.PaulHastings.com.
Polaris, a QuintilesIMS company, is the world’s leading healthcare compliance software and consulting firm, providing innovative solutions to Life Sciences companies.
Our services range from best-in-class compliance software to expert consulting, planning and strategic guidance from the industry’s leading compliance authorities. Polaris also offers competitive data analytics and end-to-end managed services.
Polaris is headquartered in New York City, with worldwide offices in Amsterdam, Boston, Hong Kong, New Brunswick, Paris and San Francisco.
Since 2001, the world’s most recognized pharmaceutical, biotech and medical device companies have relied on Polaris as their trusted life sciences compliance solutions partner. Learn more at www.polarismanagement.com.
Porzio Life Sciences helps pharmaceutical, medical device and biotechnology companies satisfy federal, state and ex-US marketing and sales obligations. Our best-in-class compliance solutions include: the Porzio Compliance Digest, with real-time databases of enacted laws, pending legislation and government enforcement actions; Porzio AggregateSpendID®, which tracks and reports healthcare provider and organization expenditures; and Porzio GST®, which enables companies to capture and manage data for meeting reporting obligations in almost 40 ex-US jurisdictions. Further, Porzio Life Sciences provides compliance services, such as assistance with acquiring and maintaining distribution licenses. For information, visit www.porziolifesciences.com.
We routinely advise clients on developing effective compliance policies to avoid the debilitating effects of government investigations, regulatory enforcement actions, or other litigation based on alleged noncompliance with applicable laws and regulations. Our command of FDA regulatory, health care compliance, research compliance and global anti-corruption issues is critical for clients operating in these highly regulated industries. For companies that are the subject of government investigations, our understanding of the government enforcement landscape enables us to defend complex proceedings involving simultaneous civil, criminal and administrative actions.
This depth and breadth of experience, coupled with our interdisciplinary team of leading regulatory, health care compliance, research compliance, government enforcement, and anti-corruption attorneys, has established us as the “go-to” firm when it comes to avoiding and successfully resolving government investigations. Our integrated practice, including our corporate transactional department, also allows clients to eliminate the inefficiencies associated with hiring multiple, independent firms.
For more information please visit www.ropesgray.com.
Sidley’s global life sciences practice comprises a team of multidisciplinary lawyers with a deep understanding of the issues innovators face—from the science and technology to the business realities. Harnessing a breadth of experience, we represent prominent pharmaceutical, biotechnology, medical device, dietary supplements and food clients on a range of regulatory, compliance and enforcement issues. Strong advocacy on behalf of our clients consistently earns our team acknowledgement from industry publications. This includes being named “Life Cycle Firm of the Year” at the inaugural LMG Life Sciences Awards in 2016. We also received first-tier national rankings in Biotechnology Law, FDA Law and Healthcare Law in the U.S. News — Best Lawyers® “Best Law Firms” rankings for the seventh consecutive year, and each year since the survey’s inception. In addition, our service and responsiveness earned us recognition in the BTI Industry Power Rankings as a “Most Recommended Law Firm in the Pharmaceutical Industry.”
For more information please visit www.Sidley.com.
Cutting Edge Information (CEI) is a Market Research Company that specializes in collecting and analyzing global FMV data. To CEI, collecting and analyzing FMV data is not an ancillary function, but our primary function.
Our data approach has been accepted by the majority of the largest pharmaceutical companies, as it reduces regulatory and compliance risk, is customizable, increases HCP acceptance of compensation fairness, and can be delivered in almost any format to meet existing FMV system needs. Our FMV customers currently include over 100 companies, and we are the provider of choice to 2 of the top 5 pharmaceutical companies in the world.
We pride ourselves on exceptional, personalized customer service, an assertion supported by the endorsements from our clients. We are the FMV data provider of choice for the pharmaceutical industry.
For more information visit www.cuttingedgeinfo.com.
Interested in becoming a Grantor or Exhibiting?
Click Here for more information or contact Justin Sorensen at 206-452-0609.